Publication | Closed Access

Association of tumour burden with the efficacy of programmed cell death-1/programmed cell death ligand-1 inhibitors for treatment-naïve advanced non-small-cell lung cancer

MedicineImmunologyPathologyBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyLung CancerCancer ResearchTumour Burden